Mitochondrial Apoptosis Induced by Extract in Breast Cancer Cells.

Journal: Iranian journal of pharmaceutical research : IJPR
Published Date:

Abstract

() commonly known as 'Roman chamomile' is a medicinal plant used for numerous diseases in traditional medicine, although its anticancer activity is unknown. The present study was carried out to investigate the anticancer as well as apoptotic activity of ethyl acetate fraction of on different cancerous cell lines. The cells were treated with varying concentrations (0.001- 0.25 mg/mL) of this fraction for 24, 48 and 72 h. Apoptosis induced in MCF-7 cells following treatment with ethyl acetate fraction was measured using Annexin V/PI, flowcytometry and western blotting analysis. The results showed that ethyl acetate fraction revealed relatively high antiproliferative activity on MCF-7 cells; however, it caused minimal growth inhibitory response in normal cells. The involvement of apoptosis as a major cause of the fraction-induced cell death was confirmed by annexin-V/PI assay. In addition, ethyl acetate fraction triggered the mitochondrial apoptotic pathway by decreasing the Bcl-2 as well as increasing of Bax protein expressions and subsequently increasing Bax/Bcl-2 ratio. Furthermore, decreased proliferation of MCF-7 cells in the presence of the fraction was associated with G2/M phase cell cycle arrest. These findings confirm that ethyl acetate fraction of may contain a diversity of phytochemicals which suppress the proliferation of MCF-7 cells by inducing apoptosis.

Authors

  • Hirsa Mostafapour Kandelous
    Physiology and Pharmacology Department, Pasteur Institute of Iran, Tehran, Iran.
  • Misha Salimi
    Physiology and Pharmacology Department, Pasteur Institute of Iran, Tehran, Iran.
  • Vahid Khori
    Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
  • Noushin Rastkari
    Center for Air Pollution Research (CAPR), Institute for Environmental Research (IER), Tehran University of Medical Sciences, Tehran, Iran.
  • Amir Amanzadeh
    National Cell Bank of Pasteur Institute of Iran, Tehran, Iran.
  • Mona Salimi
    Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran.; Physiology and Pharmacology Department, Pasteur Institute of Iran, Tehran, Iran.

Keywords

No keywords available for this article.